Clinical Trials List
Protocol NumberM17-327
Completed
2018-10-24 - 2024-01-25
Phase I
Recruiting1
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu 無
- Po-Lan Su 無
- Wen-Pin Su 無
- Chun-Hui Lee 無
- Yu-Min Yeh 無
- Wu-Chou Su Division of Hematology & Oncology
- Jui-Hung Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
200 participants
